Free Trial

Aimia (AIM) Competitors

Aimia logo
C$3.24 0.00 (0.00%)
As of 09/5/2025 04:00 PM Eastern

AIM vs. TEV, ABT, NOT, PYR, NVO, DNA, ITH, FRX, VBV, and CUS

Should you be buying Aimia stock or one of its competitors? The main competitors of Aimia include Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), International Tower Hill Mines (ITH), Fennec Pharmaceuticals (FRX), VBI Vaccines (VBV), and Chemtrade Electrochem Inc, (CUS). These companies are all part of the "pharmaceutical products" industry.

Aimia vs. Its Competitors

Tervita (TSE:TEV) and Aimia (TSE:AIM) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Tervita has higher revenue and earnings than Aimia. Aimia is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TervitaC$1.36B0.00-C$1.04M-C$0.01N/A
AimiaC$486.40M0.61-C$78.81M-C$0.08-40.50

6.1% of Aimia shares are held by institutional investors. 3.3% of Aimia shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Aimia's average media sentiment score of 0.95 beat Tervita's score of 0.00 indicating that Aimia is being referred to more favorably in the news media.

Company Overall Sentiment
Tervita Neutral
Aimia Positive

Aimia has a consensus target price of C$4.00, indicating a potential upside of 23.46%. Given Aimia's stronger consensus rating and higher probable upside, analysts clearly believe Aimia is more favorable than Tervita.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tervita
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aimia
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Tervita has a net margin of 0.00% compared to Aimia's net margin of -16.96%. Tervita's return on equity of 0.00% beat Aimia's return on equity.

Company Net Margins Return on Equity Return on Assets
TervitaN/A N/A N/A
Aimia -16.96%-14.38%-4.93%

Summary

Aimia beats Tervita on 7 of the 13 factors compared between the two stocks.

Get Aimia News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIM vs. The Competition

MetricAimiaAsset Management IndustryFinancial SectorTSE Exchange
Market CapC$295.05MC$1.44BC$6.33BC$9.37B
Dividend Yield33.90%4.59%4.31%6.53%
P/E Ratio-40.504,689.031,762.9725.65
Price / Sales0.611,971.301,359.579.34
Price / Cash0.5160.62127.5183.29
Price / Book0.561.372.055.41
Net Income-C$78.81MC$265.04MC$1.23BC$301.20M
7 Day Performance4.52%-0.30%-0.19%1.96%
1 Month Performance3.51%1.01%1.74%7.78%
1 Year Performance22.26%8.07%27.10%41.13%

Aimia Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIM
Aimia
2.0144 of 5 stars
C$3.24
flat
C$4.00
+23.5%
+22.3%C$295.05MC$486.40M-40.5020
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
ITH
International Tower Hill Mines
N/AC$2.22
+15.0%
N/A+187.9%C$461.51MN/A-111.00220News Coverage
Gap Up
High Trading Volume
FRX
Fennec Pharmaceuticals
N/AC$12.33
-0.2%
N/A+71.3%C$343.17MC$33.30M-27.4010News Coverage
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060

Related Companies and Tools


This page (TSE:AIM) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners